Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.79%
#4 aPriori aPriori +183.92%
#5 Bedrock Bedrock +80.53%
#6 Cysic Cysic +51.82%
#7 Prom Prom +45.70%
#8 Playnance Playnance +34.93%
#9 Bitway Bitway +27.53%
#10 COTI COTI +26.22%
Coin of the day
Wrapped One Wrapped One
설정
언어
한국어
통화
USD
테마
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
주식 순위 #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
주가
$0.00023723
마지막 동기화: 2024-08-26
시가총액
$1.41K
변동 (1일)
111.67%
변동 (1년)
0.00%
국가
FR
거래 Pharnext S.A. (ALPHA)

카테고리

Healthcare
Pharnext S.A. (ALPHA)의 매출
Dec 2023 기준 매출 TTM: $-487.61K
Pharnext S.A.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $-487.61K입니다. 2022년에 회사는 $598.55의 수익을 올렸으며 이는 2021년의 $96.41K 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Pharnext S.A.의 수익 기록 (2013 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $-487.61K -4,510.88%
2023 $11.05K 1,746.90%
2022 $598.55 -99.38%
2021 $96.41K 98.76%
2020 $48.51K -82.90%
2019 $283.61K -96.39%
2018 $7.85M 96.92%
2017 $3.99M -14.33%
2016 $4.65M 62.80%
2015 $2.86M -14.35%
2014 $3.34M -7.92%
2013 $3.62M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -2,589,130.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -1,234,964.32%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -2,073,651.57%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR